Cue Biopharma CUE
NASDAQ CUE
$23.98 -0.63 (-2.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Sales of Property, Plant and Equipment (2019 - 2025)

Cue Biopharma (CUE) Sales of Property, Plant and Equipment (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cue Biopharma 152.56 Mn 135.14 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 20,000.00
Dec 31, 2025 20,000.00
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Sep 30, 2024 97,000.00
Sep 30, 2024 97,000.00
Mar 31, 2023 2,000.00
Mar 31, 2023 2,000.00
Sep 30, 2022 3,000.00
Sep 30, 2022 3,000.00
Jun 30, 2022 3,000.00
Jun 30, 2022 3,000.00
Dec 31, 2021 550.00
Dec 31, 2021 550.00
Sep 30, 2021 2,000.00
Sep 30, 2021 2,000.00
Dec 31, 2019 500.00
Dec 31, 2019 500.00